Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
4.220
+0.090 (2.18%)
At close: Nov 17, 2026, 4:00 PM EST
4.080
-0.140 (-3.32%)
After-hours: Nov 17, 2026, 5:08 PM EST
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $13.58 million as of November 17, 2026. It is the 39,486th most valuable company in the world and the 5,366th biggest in the United States. Its market cap has decreased by 51.73% in one year.
Market Cap
13.58M
Enterprise Value
-6.58M
1-Year Change
-51.73%
Global Rank
Country Rank
#5,366 United States
Category
ChartMarket Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $13.58M, a decrease of -98.58%. That is a compound annual growth rate of -46.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 13.60M | -63.75% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| NewcelX | 15.08M |
| Citius Pharmaceuticals | 14.69M |
| Marker Therapeutics | 14.51M |
| Seres Therapeutics | 14.27M |
| Quantum BioPharma | 14.11M |
| Kyntra Bio | 13.93M |
| Neuphoria Therapeutics | 13.80M |
| Aligos Therapeutics | 13.12M |